Publication | Closed Access

Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model

NanomedicineRna AptamersPegylated Liposomal DoxorubicinNanotherapeuticsDrug TargetingPolymer-drug ConjugateMedicineTargeted Drug DeliveryDrug Delivery SystemsNano-drug DeliveryTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyTumor BiologyHealth Sciences